CTRI/2022/05/042735
Completed
未知
Effect of mirabegron on catheter-related bladder dysfunction following elective gynecological surgery under general anesthesia- a randomized controlled trial.
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: N70-N77- Inflammatory diseases of female pelvic organs
- Sponsor
- AIIMS Bhubaneswar
- Enrollment
- 88
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\-Undergoing elective gynecological surgery under general anesthesia requiring postoperative urinary catheterization
- •2\-Surgical duration is less than 4 hr.
Exclusion Criteria
- •1\-History of Coronary artery disease. Hypertension \> 150mmHg in initial 48hrs before surgery, Patient on Digoxin, or Drugs are known to prolong the QT/QTc interval.
- •2\-Known bladder dysfunction, such as overactive bladder, neurogenic bladder
- •3\-Pregnant or breastfeeding
- •4\-Intellectual disability
- •5\-Chronic renal insufficiency (creatinine \>1\.5mg/dL) or liver insufficiency (bilirubin \>34\.2mmol/L),
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Effect of Mirabegron on Bladder CompliancePatients With Low Bladder Compliance of 20ml/H2O or Less Despite Taking AnticholinergicsNCT05745584Yonsei University15
Active, not recruiting
Phase 1
Mirabegron in the management of lower urinary tract symptoms (LUTS) related to double-J (JJ) ureteral stents.Insertion of a JJ stent, prior to extracorporal shock wave lithotripsy (ESWL) and post ureterolithotripsy.MedDRA version: 19.0Level: LLTClassification code 10046707Term: UrolithiasisSystem Organ Class: 100000004857Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Surgical Procedures, Operative [E04]EUCTR2015-004013-25-GRInstitute of Molecular Medicine and Biomedical Research- I.M.B.E.
Completed
Phase 3
Mirabegron Treatment on Patients With Overactive Bladder Syndrome in TaiwanUrinary IncontinenceOveractive Bladder SyndromeNCT03059134Buddhist Tzu Chi General Hospital168
Completed
Not Applicable
Efficacy of mirabegron for voiding disorders in patient who underwent prostate low-dose-rate brachytherapyprostate cancerJPRN-UMIN000022613ara Medical University Department of Urology218
Completed
Phase 2
Effect of Pregabalin Administration on Catheter- Related Bladder Discomfort in Urological Surgical OperationsPregabalin on Catheter Related Bladder DiscomfortNCT03229668Saint Savvas Anticancer Hospital78